Blood pressure management in patients with diabetes

Clinical Diabetes

Volumn 28, Issue 3, 2010, Pages 107-114

  Salanitro, Amanda H ^a   Roumie, Christianne L ^b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CANDESARTAN; CAPTOPRIL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; EPROSARTAN; FELODIPINE; FOSINOPRIL; IRBESARTAN; LISINOPRIL; LOSARTAN; MOEXIPRIL; NISOLDIPINE; OLMESARTAN; PERINDOPRIL; PLACEBO; QUINAPRIL; RAMIPRIL; TELMISARTAN; THIAZIDE DIURETIC AGENT; TRANDOLAPRIL; VALSARTAN;

BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BRADYCARDIA; BRONCHOSPASM; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL TRIAL; CONSTIPATION; DEATH; DEPRESSION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRY COUGH; EDEMA; FATIGUE; FLUSHING; HALLUCINATION; HEADACHE; HEART FAILURE; HEART INFARCTION; HEART RATE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPOKALEMIA; HYPONATREMIA; HYPOTENSION; IMPOTENCE; KIDNEY DISEASE; KIDNEY DYSFUNCTION; LIFESTYLE MODIFICATION; MEDICAL LITERATURE; MUSCLE CRAMP; MYALGIA; NAUSEA; NIGHTMARE; PRIMARY MEDICAL CARE; RETINOPATHY; REVIEW; SIDE EFFECT; STROKE; WEIGHT GAIN;

EID: 77957223207     PISSN: 08918929     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaclin.28.3.107     Document Type: Review

References (51)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JLJ, Jones DW, Materson BJ, Oparil S, Wright JTJ, Roccella EJ, National Heart Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and Committee NHBPEPC: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 289:2560-2571, 2003
2. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Gillespie C, Go A, Greenlund K, Haase N, Hailpern S, Ho PM, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott MM, Meigs J, Mozaffarian D, Mussolino M, Nichol G, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Thom T, Wasserthiel-Smoller S, Wong ND, Wylie-Rosett J; American Heart Association Statistics Committee and Stroke Statistics Subcommittee: Heart disease and stroke statistics-2010 update: a report from the American Heart Association. Circulation 121:e46-e215, 2010
3. National Institutes of Health Morbidity & Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases [article online], 2009. Available from http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook_508.pdf. Accessed 20 February 2010
4. Simonson DC: Etiology and prevalence of hypertension in diabetic patients. Diabetes Care 11:821-827, 1988
5. Hypertension in Diabetes Study (HDS): I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 11:309-317, 1993
6. Arauz-Pacheco C, Parrott MA, Raskin P: The treatment of hypertension in adult patients with diabetes. Diabetes Care 25:134-147, 2002
7. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR: Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321:412-419, 2000
8. U.K. Prospective Diabetes Study Group: Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 317:703-713, 1998
9. Holman RR, Paul SK, Bethel MA, Neil HAW, Matthews DR: Long-term follow-up after tight control of blood pressure in type 2 diabetes. N Engl J Med 359:1565-1576, 2008
10. Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S: Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755-1762, 1998
11. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G: Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342:145-153, 2000
12. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253-259, 2000
13. Whelton PK, Barzilay J, Cushman WC, Davis BR, Iiamathi E, Kostis JB, Leenen FH, Louis GT, Margolis KL, Mathis DE, Moloo J, Nwachuku C, Panebianco D, Parish DC, Pressel S, Simmons DL, Thadani U: Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 165:1401-1409, 2005
14. Estacio RO, Jeffers BW, Hiatt WR, Biggerstaff SL, Gifford N, Schrier RW: The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension. N Engl J Med 338:645-652, 1998
15. Estacio RO, Jeffers BW, Gifford N, Schrier RW: Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 23 (Suppl. 2):B54-B64, 2000
16. Cushman WC, Grimm RH Jr, Cutler JA, Evans GW, Capes S, Corson MA, Sadler LS, Alderman MH, Peterson K, Bertoni A, Basile JN: Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol 99 (Suppl. 12):S44-S55, 2007
17. National Institutes of Health: Landmark ACCORD trial finds intensive blood pressure and combination lipid therapies do not reduce combined cardiovascular events in adults with diabetes [article online], 2010. Available from http://www.nih.gov/news/health/mar2010/nhlbi-15.htm. Accessed 20 February 2010
18. McWilliams JM, Meara E, Zaslavsky AM, Ayanian JZ: Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of Medicare coverage. Ann Intern Med 150:505-515, 2009
19. Saaddine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor F, Imperatore G, Narayan KM: Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 144:465-474, 2006
20. World Health Organization: Adherence to long-term therapies: evidence for action [article online], 2003. Available from http://www.who.int/chp/knowledge/publications/adherence_report/en. Accessed 20 February 2010
21. Turner BJ, Hollenbeak C, Weiner MG, Ten Have T, Roberts C: Barriers to adherence and hypertension control in a racially diverse representative sample of elderly primary care patients. Pharmacoepidemiol Drug Saf 18:672-681, 2009
22. Doroodchi H, Abdolrasulnia M, Foster JA, Foster E, Turakhia MP, Skelding KA, Sagar K, Casebeer LL: Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract 9:42, 2008
23. Bodenheimer T: A 63-year-old man with multiple cardiovascular risk factors and poor adherence to treatment plans. JAMA 298:2048-2055, 2007
24. Bolen SD, Samuels TA, Yeh HC, Marinopoulos SS, McGuire M, Abuid M, Brancati FL: Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension. J Gen Intern Med 23:543-550, 2008
25. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, Selby JV: Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med 23:588-594, 2008
26. Roumie CL, Elasy TA, Wallston KA, Pratt S, Greevy RA, Liu X, Alvarez V, Dittus RS, Speroff T: Clinical inertia: a common barrier to changing provider prescribing behavior. Jt Comm J Qual Patient Saf 33:277-285, 2007
27. Cooper LA: A 41-year-old African-American man with poorly controlled hypertension: review of patient and physician factors related to hypertension treatment adherence. JAMA 301:1260-1272, 2009
28. Naik AD, Kallen MA, Walder A, Street RL Jr: Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication. Circulation 117:1361-1368, 2008
29. Simon SR, Majumdar SR, Prosser LA, Salem-Schatz S, Warner C, Kleinman K, Miroshnik I, Soumerai SB: Group versus individual academic detailing to improve the use of antihypertensive medications in primary care: a cluster-randomized controlled trial. Am J Med 118:521-528, 2005
30. Peterson KA, Radosevich DM, O'Connor PJ, Nyman JA, Prineas RJ, Smith SA, Arneson TJ, Corbett VA, Weinhandl JC, Lange CJ, Hannan PJ: Improving diabetes care in practice: findings from the TRANSLATE trial. Diabetes Care 31:2238-2243, 2008
31. Krein SL, Klamerus ML, Vijan S, Lee JL, Fitzgerald JT, Pawlow A, Reeves P, Hayward RA: Case management for patients with poorly controlled diabetes: a randomized trial. Am J Med 116:732-739, 2004
32. Roumie CL, Elasy TA, Greevy R, Griffin MR, Liu X, Stone WJ, Wallston KA, Dittus RS, Alvarez V, Cobb J, Speroff T: Improving blood pressure control through provider education, provider alerts, and patient education: a cluster randomized trial. Ann Intern Med 145:165-175, 2006
33. Choma NN, Huang RL, Dittus RS, Burnham KE, Roumie CL: Quality improvement initiatives improve hypertension care among veterans. Circ Cardiovasc Qual Outcomes 2:392-398, 2009
34. Estrada C, Salanitro A, Safford M, Curry W, Williams J, Ovalle F, Payne-Foster P, Kim Y, Houston T, Allison J: A cluster-randomized trial of a web-based physician intervention to improve diabetes care (Abstract). J Invest Med 58:512, 2010
35. Deakin T, McShane CE, Cade JE, Williams RD: Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev CD003417, 2005
36. Carter BL, Rogers M, Daly J, Zheng S, James PA: The potency of team-based care interventions for hypertension: a meta-analysis. Arch Intern Med 169:1748-1755, 2009
37. Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A: Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev CD003638, 2005
38. American Diabetes Association: Executive summary: standards of medical care in diabetes-2010. Diabetes Care 33 (Suppl. 1):S4-S10, 2010
39. Banegas JR, Messerli FH, Waeber B, Rodriguez-Artalejo F, de la Sierra A, Segura J, Roca-Cusachs A, Aranda P, Ruilope LM: Discrepancies between office and ambulatory blood pressure: clinical implications. Am J Med 122:1136-1141, 2009
40. Dolan E, Stanton A, Thijs L, Hinedi K, Atkins N, McClory S, Den Hond E, McCormack P, Staessen JA, O'Brien E: Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension 46:156-161, 2005
41. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C: Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 19:243-250, 2006
42. Moore TJ, Vollmer WM, Appel LJ, Sacks FM, Svetkey LP, Vogt TM, Conlin PR, Simons-Morton DG, Carter-Edwards L, Harsha DW: Effect of dietary patterns on ambulatory blood pressure: results from the Dietary Approaches to Stop Hypertension (DASH) trial. Hypertension 34:472-477, 1999
43. KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis 49 (Suppl. 2):S12-S154, 2007
44. Tatti P, Pahor M, Byington RP, Di Mauro P, Guarisco R, Strollo G, Strollo F: Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. Diabetes Care 21:597-603, 1998
45. Whalen KL, Stewart RD: Pharmaco-logic management of hypertension in patients with diabetes. Am Fam Phys 78:1277-1282, 2008
46. Bakris GL: The importance of blood pressure control in the patient with diabetes. Am J Med 116 (Suppl. 5A):30S-38S, 2004
47. Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ: Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 122:290-300, 2009
48. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 114 (Suppl. 2):555-576, 2004
49. Din-Dzietham R, Liu Y, Bielo MV, Shamsa F: High blood pressure trends in children and adolescents in national surveys, 1963 to 2002. Circulation 116:1488-1496, 2007
50. Ford ES, Mokdad AH, Ajani UA: Trends in risk factors for cardiovascular disease among children and adolescents in the United States. Pediatrics 114:1534-1544, 2004
51. Steinberger J, Daniels SR, Eckel RH, Hayman L, Lustig RH, McCrindle B, Mietus-Snyder ML: Progress and challenges in metabolic syndrome in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascular Disease in the Young; Council on Cardiovascular Nursing; and Council on Nutrition, Physical Activity, and Metabolism. Circulation 119:628-647, 2009